A randomized controlled clinical trial to assess the safety and efficacy of RAVICTI in treatment naive patients with urea cycle disorders (UCD)

Trial Profile

A randomized controlled clinical trial to assess the safety and efficacy of RAVICTI in treatment naive patients with urea cycle disorders (UCD)

Planning
Phase of Trial: Phase IV

Latest Information Update: 12 Dec 2015

At a glance

  • Drugs Glycerol phenylbutyrate (Primary) ; Sodium phenylbutyrate
  • Indications Inborn urea cycle disorders
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 Dec 2015 New trial record
    • 04 Mar 2015 According to the company SEC filing report 10-K 2014, this study is expected to start enrolling in the second half of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top